Subsidies
Subsidies
subsidy
| Title | Code of transcript | Funder | Beneficiary Entity | Call for applications | Date of award | Amount Awarded | Other Funds |
|---|---|---|---|---|---|---|---|
| Decross-priming dendritic cells as vaccines in an immunotherapy strategy for renal and urothelial cancers. | ICI22/00115 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES research Independent Clinic | 16-12-2022 | 1.007.600,00€ | MRR Funds |
| essay Phase I/II clinical trial for the treatment of graft-versus-host disease with a new generation of mesenchymal stromal cells ectopically expressing CXCR4 and IL10 | ICI22/00067 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES research Independent Clinic | 16-12-2022 | 1.207.250,00€ | - |
| Patient Dignity Question as an intervention for the alleviation of suffering: A mixed-method study in patients with advanced disease. | PI22/01504 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES Projects research | 15-12-2022 | 10.890,00€ | ERDF funds |
| Diagnostic platform of high performing for personalized medicine in patients with acute myeloblastic leukemia. | PMP22/00069 | HIGH SCHOOL CARLOS III HEALTH CENTRE | University of Navarra | 2022 AES Personalized Medicine | 15-12-2022 | 126.252,67€ | - |
| Linking phenotype and molecular genotype to prognosis in Primary Systemic Amyloidosis: A European registry and network of samples to optimize diagnosis and management of Primary Systemic Amyloidosis. | AC22/00057 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2022 AES International Joint Programming Projects | 15-12-2022 | 174.845,00€ | MRR Funds |
